↧
Preclinical study finds antitumor effects of bispecific antibody
Chugai Pharmaceutical announced today that the preclinical study findings on its original bispecific antibody ERY974, a molecule that binds Glypican-3 and CD3 simultaneously, and that is currently...
View ArticleVisceral adipose tissue index IDs risk of HCC in cirrhosis
(HealthDay)—For male patients with cirrhosis, visceral adipose tissue index (VATI) is an independent risk factor for hepatocellular carcinoma (HCC), according to a study published online Oct. 10 in...
View ArticleLiver cancer: Lipid synthesis promotes tumor formation
Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the...
View Article